Moreover, ongoing research is essential to fully understand the scope of its applications and any potential long-term effects
Everywhere you look it seems these medications, which mimic the hormone glucagon-like peptide-1, are being promoted
Researchers also noted a lower incidence of disease in this group
In their study, Elgogary et al
(PubMed) Parente E, Colannino G, Picconi O, Monastra G
Some people are hitting a weight loss plateau with GLP-1 agonist drugs like Ozempic, so theyre turning to a stronger variety that promises even more dramatic weight loss up to more than 70 pounds in some instances, The Atlantic reports